Investigator Initiated Trials
ADC Therapeutics and our partners accept unsolicited proposals requesting support to conduct Investigator Initiated Trials (IITs) for our products. Proposals must align with ADC Therapeutics’ strategic areas of interest, including but not limited to:
- Clinical interventions assessing unmet medical needs, novel combinations, new indications, and various patient populations in therapeutic areas of interest
- Non-interventional studies
- Translational and observational studies
Investigators can submit and track the progress of their proposals through the IIT portal. Proposals are reviewed for scientific merit as well as compliance with legal, ethical, and professional obligation prior to endorsement.
Please submit IIT proposals to our partner Sobi for those proposed outside of the United States, excluding Greater China, Singapore and Japan, via their portal.